stockrowCytokinetics, Incorporated
CYTK Healthcare Biotechnology
Cytokinetics, Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $88.0 million, up 376.6% from fiscal 2024.
- Revenue
- +2,356.5%
- EPS
- +46.3%
- Free cash flow
- −6.73%
- Total debt
- −83.9%
Quarter to September 2026, against a year earlier
Follow CYTK
Alert me
Cytokinetics, Incorporated (CYTK) Shares outstanding
Cytokinetics, Incorporated's shares outstanding at the end of fiscal 2025 was $120.1M, up 7.25% from $112.0M in fiscal 2024. At the end of the quarter to 30 June 2026 it was $132.1M. Over the past ten years it has ranged from $38.8M (fiscal 2015) to $120.1M (fiscal 2025) — the current reading is the highest in ten years. Cytokinetics, Incorporated ranks 95th of 600 Biotechnology companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $120.1M | 7.25% |
| FY2024 | $112.0M | 16.01% |
| FY2023 | $96.5M | 7.46% |
| FY2022 | $89.8M | 16.83% |
| FY2021 | $76.9M | 19.16% |
| FY2020 | $64.5M | 12.07% |
| FY2019 | $57.6M | 5.80% |
| FY2018 | $54.4M | 10.15% |
| FY2017 | $49.4M | 16.08% |
| FY2016 | $42.6M | 9.65% |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Jun 2026 | $132.1M | 7.15% |
| Mar 2026 | $123.3M | 2.64% |
| Dec 2025 | $120.1M | 0.10% |
| Sep 2025 | $120.0M | 0.44% |
| 42 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| CAI Caris Life Sciences,�Inc. compare | $295.1M |
| ARWR Arrowhead Pharmaceuticals, Inc. compare | $143.4M |
| CYTK Cytokinetics, Incorporated | $132.1M |
| CORT Corcept Therapeutics Incorporated compare | $123.2M |
| SYRE Spyre Therapeutics, Inc. compare | $88.4M |
| PTGX Protagonist Therapeutics, Inc. compare | $71.0M |
| TWST Twist Bioscience Corporation compare | $62.4M |
| KRYS Krystal Biotech, Inc. compare | $30.8M |
| MDGL Madrigal Pharmaceuticals, Inc. compare | $30.3M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on CYTK
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement